Landscapes / Companies

Phanes Therapeutics not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 2
 
Next date
Mavrostobart, Phase 1/2 trial completes
Drugs
3
in active trials
Trials
3 active
3 since 2021

Drugs3

DrugHow it worksPartnerStageNext dateDetails
Artificial immunoglobulin
Phase 1/2 Dec 2027Phase 1/2 trial completes
Multi-specific immunoglobulin
Phase 1/2 Dec 2027Phase 1/2 trial completes
Multi-specific immunoglobulin
Phase 1/2 Dec 2027Phase 1/2 trial completes

About

SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Phanes Therapeutics

Following is part of Solo: you see every change to Phanes Therapeutics the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in